Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile

GlobalData
44 Pages - GLDATA61960
$250.00

Summary

Biohit Oyj (Biohit) is a biotechnology company that offers research and early diagnosis processing products. The company’s products include acetaldehyde binding products, diagnostic tests, monoclonal antibodies, laboratory instruments and pipettes. It targets therapeutic areas of gastric cancer, gastroesophageal reflux disease (GERD) and colorectal cancer and others. Biohit’s laboratory equipment comprise microplate instruments, automates and liquid handling products to support Biohit ELISA tests. The company also offers tests for the diagnosis of lactose intolerance and helicobacter pylori infection. Its monoclonal antibodies are used for research purpose and use as raw materials for diagnostic industry. The company has its presence in Italy and the UK. Biohit is headquartered in Helsinki, Finland.

Biohit Oyj (BIOBV) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Biohit Oyj, Medical Equipment, Deals By Year, 2011 to YTD 2017 4
Biohit Oyj, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Biohit Oyj, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Biohit Oyj, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Biohit Oyj, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Biohit Oyj, Medical Equipment, Deal Details 10
Asset Purchase 10
Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million 10
Partnerships 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 10
Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 11
Biohit Enters into Distribution Agreement with Genetic Analysis 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 13
Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 14
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 15
Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 16
Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 16
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 17
Acquisition 18
Biohit Acquires 18% Stake in Genetic Analysis 18
Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 19
Biohit Oyj - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Feb 20, 2017: Biohit Group Financial Statement Release 2016 24
Aug 18, 2016: Biohit Group Half Year Financial report 2016 29
Corporate Communications 42
Aug 26, 2016: Ilari Patrakka appointed Biohit Oyj’s Sales and Marketing Director 42
Legal and Regulatory 43
Oct 24, 2016: Biohit’s Chinese joint venture to start production - Gastric cancer risk screening study progressing in China 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Biohit Oyj, Medical Equipment, Key Facts, 2015 1
Biohit Oyj, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Biohit Oyj, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Biohit Oyj, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Biohit Oyj, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Biohit Oyj, Deals By Market, 2011 to YTD 2017 8
Biohit Oyj, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Biohit Acquires Rights To UFT300 Test From Advanced Biomedical Systems For US$0.5 Million 10
Biohit Enters Into Licensing Agreement With Randox For GastroPanel Test 10
Biohit Enters into Distribution Agreement with Pooyandegan Pezeshki Pardis 11
Biohit Enters into Distribution Agreement with Genetic Analysis 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Biohit Forms Joint Venture with Anhui Wisdom-Win Investment 13
Ferring Pharma Enters Into Distribution Agreement With Biohit Healthcare For PreventID CalScreen 14
Biohit Enters Into Distribution Agreement With IBL International For GastroPanel 15
Biohit Enters Into Distribution Agreement With Hefei Medicine For GastroPanel Test 16
Biohit Enters Into Distribution Agreement With Fisher Scientific For Diagnostic Products 16
Biohit Enters Into Distribution Agreement With Euro-Diagnostica For GastroPanel 17
Biohit Acquires 18% Stake in Genetic Analysis 18
Biohit Completes Acquisition of Euroclone Gastro from Euroclone for USD1.48 Million 19
Biohit Oyj, Key Competitors 21
Biohit Oyj, Key Employees 22
Biohit Oyj, Subsidiaries 23

List of Figures
Biohit Oyj, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Biohit Oyj, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Biohit Oyj, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Biohit Oyj, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Biohit Oyj, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Biohit Oyj, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Biohit Oyj, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Biohit Oyj, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838